LUMO

Lumos Pharma, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.34

+0.00 (+0.00%)

Company Profile

CEO

Richard J. Hawkins

IPO Date

2011-11-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$4.33

Prev. Close

$4.34

Day Low

$4.33

Day High

$4.34

52W Low

$1.37

52W High

$4.58

Market Cap

$0.04B

Volume

0.39M

News SentimentNeutral

Articles

Avg Positive

13.5%

Avg Negative

13.3%

Avg Neutral

73.2%

News Feed

Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board

GlobeNewsWire·7/26/2021·↑ positive

Lumos Pharma Delays Data Readout From Pediatric Growth Hormone Deficiency Trial To 2H Of 2023

Benzinga·7/21/2021·↓ negative

Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q1 2021 Results - Earnings Call Transcript